General Information
|
|
Product
|
Apelin Receptor Antibody FITC
|
Verified Applications
|
ELISA, IHC, IP, WB
|
Host
|
Rabbit
|
Species Cross Reactivity
|
Human
|
Immunogen
|
Synthetic peptide taken within amino acid region 150-200 human Apelin receptor protein.
|
Accession #
|
NCBI: NP_005152
|
Physical Properties
|
|
Quantity
|
100 µg
|
Volume
|
200 µl
|
Concentration
|
0.5 µg/µl in antibody stabilization buffer
|
Immunoglobulin
|
IgG
|
Form
|
FITC-Conjugated
|
Purification Method
|
Immobilized antigen affinity chromatography
|
Clonality
|
Polyclonal
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
ELISA
|
1:50,000
|
Immunohistochemistry |
1:50-1:150 |
Immunoprecipitation
|
1:200
|
Western Blot
|
1:500
|
Protein
|
Uniprot #
|
P35414
|
Overview
|
Receptor for apelin coupled to G proteins that inhibit adenylate cyclase activity and plays a role in various processes in adults such as regulation of blood pressure, heart contractility, and heart failure. Also plays a key role in early development such as gastrulation and heart morphogenesis by acting as a receptor for APELA hormone. Alternative coreceptor with CD4 for HIV-1 infection; may be involved in the development of AIDS dementia.
|
Molecular Function
|
Developmental protein, G-protein coupled receptor, Receptor, Transducer
|
Subcellular Location
|
Cell membrane, Multi-pass membrane protein
|
Expression
|
Widely expressed in the brain, in glial cells, astrocytes and neuronal subpopulations, as well as in the spleen, thymus, ovary, small intestine and colon.
|
Structure
|
Transmembrane, Transmembrane helix
|
Alternative Nomenclature
|
AGTRL1 ligand antibody
APEL antibody
Apelin-13 antibody
APJ endogenous ligand antibody
Apln antibody
XNPEP2 antibody
|
|
|